Skip to main content
Premium Trial:

Request an Annual Quote

Biomarker Standardization to Play Role in NCI s Plan to Revamp Cancer Clincial Trials

NEW YORK, June 8 (GenomeWeb News) - In its ongoing effort to "revamp" its clinical trial program, the National Cancer Institute approved suggestions to develop methods to standardize the way biomarker data are measured, analyzed, and reported, according to the institute.

 

The effort is part of a broader announcement by the NCI stating that its National Cancer Advisory Board had accepted 22 proposals friom the Clinical Trials Working Group outlining steps the NCI can take to improve the institute's cancer clinical trials system. The CTWG's proposal also includes a five-year plan to accomplish the changes.

Among the proposed changes, the CTWG suggests that the NCI should "develop a standards-setting process for the measurement, analysis, and reporting of biomarker data in association with clinical trials to enhance data comparisons, reduce duplication, and facilitate data submission for regulatory approval," according to a statement released by the institute yesterday.

"Advances in molecular medicine are the driving force behind the Clinical Trials Working Group recommendations," the NCI said in the statement. "These advances offer enormous potential to improve cancer clinical practice by advancing beyond the toxic treatments of the past, but also create new challenges for the design and conduct of cancer clinical trials."
 
The CTWG's report, which can be found here, includes an implementation plan with a timeline and budget for each of the 22 initiatives.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.